Learn everything you need to know about Ambroxol-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over 12 months, whereas placebo patients worsened. Those with high-risk genes ...

Please provide your email address to receive an email when new articles are posted on . Although a high number of adverse events were logged, most were mild to moderate in severity. The effects of ...

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has started a safety review of medicines that contain ambroxol and bromhexine. The medicines are used as ...

In a small clinical trial in Canada, a medicine commonly found in European cough syrups has shown early signs it might do something no approved treatment for Parkinson’s disease dementia has yet ...

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in Parkinson's disease-related dementia. The drug, ambroxol, isn't approved for use in ...

Review the side-effects of Ambroxol as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Medicines containing ambroxol or bromhexine carry a small risk for severe skin reactions, which include erythema multiforme and Stevens-Johnson syndrome, and the product labels should be updated to ...

Researchers at Lawson Research Institute are studying Ambroxol - a common cough medicine in Europe - as a potential treatment for dementia linked to Parkinson’s disease LONDON, Ont. – Dementia poses a ...

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s disease, a new study suggests. Nearly half of those diagnosed with Parkinson’s ...